Product Images Nurtec Odt
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Nurtec Odt NDC 72618-3000 by Pfizer Laboratories Div Pfizer Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
nurtec 01
nurtec 02
nurtec 03
This is a graph representing the percentage of individuals who achieved pain freedom with NURTEC ODT 75mg as compared to a placebo. The graph shows a 100% pain freedom rate with NURTEC ODT 75mg and a significantly lower rate with the placebo. The time frame for achieving pain freedom is also displayed in hours.*
nurtec 04
The text is describing a graph showing the percentage of patients achieving MBS freedom after taking NURTEC ODT 75 mg compared to a placebo. The graph shows that at all time points from 0.5 to 20 hours after the dose, NURTEC ODT was significantly more effective in achieving MBS freedom compared to the placebo.*
nurtec 05
nurtec 06
nurtec 07
nurtec 10
Nurtec® ODT (rimegepant) is a medication that comes in the form of orally disintegrating tablets containing 75 mg of rimegepant. The medication is accessed by peeling back the foil from the blister pack and placing the tablet under or on top of the tongue where it dissolves within seconds. The recommended storage temperature is 68°F to 77°F (20°C to 25°C) with temporary excursions allowed between 59°F to 86°F (15°C to 30°C). For more information or questions about the medication, individuals can visit the Nurtec website or call the provided phone number.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.